Skip to main
KIN
KIN logo

Kindred Biosciences (KIN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Kindred Biosciences (KIN) Stock

About Kindred Biosciences (KIN)

Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals. Its strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and t...read more
Market cap$420.53M
Today's volume
Revenue (TTM)
Avg. daily volume1.54M
EBITDA (TTM)
Open
Price / earnings ratio-9.02x
Today's range
Debt / equity
52 week range$3.46 - $9.28
5 year debt / equity11.69x
Beta (LTM)1x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 5, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 10, 2025, the market cap for KIN stock is $420.53M

The current P/E ratio for KIN stock is -9.02

The 52-week high for KIN stock is $9.28. The current KIN stock price $undefined is 100.00% below its 52-week high

The 52-week low for KIN stock is $3.46. The current KIN stock price $undefined has increased 100.00% from its 52-week low

No, the KIN stock does not pay dividends to its shareholders

How to buy KIN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KIN stock

    Navigate to the Explore page. Then, type KIN into the search bar. When you see KIN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KIN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Kindred Biosciences Stock Earnings

The value each KIN share was expected to gain vs. the value that each KIN share actually gained.

Kindred Biosciences (KIN) reported Q2 2021 earnings per share (EPS) of -$0.20, missing estimates of -$0.16 by 25.00%. In the same quarter last year, Kindred Biosciences's earnings per share (EPS) was $0.60. Kindred Biosciences is expected to release next earnings on 08/05/2021, with an earnings per share (EPS) estimate of $0.

Buy Kindred Biosciences (KIN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.